These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

378 related items for PubMed ID: 9300934

  • 21. Changes of antipyrine pharmacokinetics during influenza and after administration of interferon-alpha and -beta.
    Brockmeyer NH, Barthel B, Mertins L, Goos M.
    Int J Clin Pharmacol Ther; 1998 Jun; 36(6):309-11. PubMed ID: 9660037
    [Abstract] [Full Text] [Related]

  • 22. Impaired absorption of zidovudine in patients with AIDS-related small intestinal disease.
    Kapembwa MS, Fleming SC, Orr M, Wells C, Bland M, Back D, Griffin GE.
    AIDS; 1996 Nov; 10(13):1509-14. PubMed ID: 8931785
    [Abstract] [Full Text] [Related]

  • 23. Plasma levels of zidovudine twice daily compared with three times daily in six HIV-1-infected children.
    Bergshoeff AS, Fraaij PL, Verweij C, van Rossum AM, Verweel G, Hartwig NG, de Groot R, Burger DM.
    J Antimicrob Chemother; 2004 Dec; 54(6):1152-4. PubMed ID: 15537694
    [Abstract] [Full Text] [Related]

  • 24. Multidose pharmacokinetics of ritonavir and zidovudine in human immunodeficiency virus-infected patients.
    Cato A, Qian J, Hsu A, Levy B, Leonard J, Granneman R.
    Antimicrob Agents Chemother; 1998 Jul; 42(7):1788-93. PubMed ID: 9661022
    [Abstract] [Full Text] [Related]

  • 25. Effects of spontaneous gastric hypoacidity on the pharmacokinetics of zidovudine and didanosine.
    Shelton MJ, Adams JM, Hewitt RG, Steinwandel C, DeRemer M, Cousins S, Morse GD.
    Pharmacotherapy; 1997 Jul; 17(3):438-44. PubMed ID: 9165548
    [Abstract] [Full Text] [Related]

  • 26. Pharmacokinetic study of the combination of tacrolimus and fluconazole in renal transplant patients.
    Lumlertgul D, Noppakun K, Rojanasthien N, Kanchanarattanakorn K, Jittikanont S, Manoyot A, Bunnachak D, Ophascharoensuk V.
    J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S73-8. PubMed ID: 17044457
    [Abstract] [Full Text] [Related]

  • 27. Pharmacokinetic optimization of the treatment of oral candidiasis with fluconazole: studies with a suspension.
    Laufen H, Yeates RA, Zimmermann T, de los Reyes C.
    Drugs Exp Clin Res; 1995 Aug; 21(1):23-8. PubMed ID: 7796709
    [Abstract] [Full Text] [Related]

  • 28. Pharmacokinetics of single and chronic dose zidovudine in two HIV positive patients undergoing continuous ambulatory peritoneal dialysis (CAPD).
    Gallicano KD, Tobe S, Sahai J, McGilveray IJ, Cameron DW, Kriger F, Garber G.
    J Acquir Immune Defic Syndr (1988); 1992 Aug; 5(3):242-50. PubMed ID: 1740749
    [Abstract] [Full Text] [Related]

  • 29. Intravenous and oral zidovudine pharmacokinetics and coagulation effects in asymptomatic human immunodeficiency virus-infected hemophilia patients.
    Morse GD, Portmore AC, Marder V, Plank C, Olson J, Taylor C, Bonnez W, Reichman RC.
    Antimicrob Agents Chemother; 1992 Oct; 36(10):2245-52. PubMed ID: 1444306
    [Abstract] [Full Text] [Related]

  • 30. Pharmacokinetics of fluconazole in the cerebrospinal fluid of children with hydrocephalus.
    Bafeltowska JJ, Buszman E.
    Chemotherapy; 2005 Oct; 51(6):370-6. PubMed ID: 16227694
    [Abstract] [Full Text] [Related]

  • 31. Efficacy of melaleuca oral solution for the treatment of fluconazole refractory oral candidiasis in AIDS patients.
    Jandourek A, Vaishampayan JK, Vazquez JA.
    AIDS; 1998 Jun 18; 12(9):1033-7. PubMed ID: 9662200
    [Abstract] [Full Text] [Related]

  • 32. Pharmacokinetics of fluconazole in people with HIV infection: a population analysis.
    McLachlan AJ, Tett SE.
    Br J Clin Pharmacol; 1996 Apr 18; 41(4):291-8. PubMed ID: 8730974
    [Abstract] [Full Text] [Related]

  • 33. Dose-dependent inhibition of CYP3A activity by clarithromycin during Helicobacter pylori eradication therapy assessed by changes in plasma lansoprazole levels and partial cortisol clearance to 6beta-hydroxycortisol.
    Ushiama H, Echizen H, Nachi S, Ohnishi A.
    Clin Pharmacol Ther; 2002 Jul 18; 72(1):33-43. PubMed ID: 12152002
    [Abstract] [Full Text] [Related]

  • 34. Lack of pharmacokinetic interaction between amdoxovir and reduced- and standard-dose zidovudine in HIV-1-infected individuals.
    Hurwitz SJ, Asif G, Fromentin E, Tharnish PM, Schinazi RF.
    Antimicrob Agents Chemother; 2010 Mar 18; 54(3):1248-55. PubMed ID: 20038617
    [Abstract] [Full Text] [Related]

  • 35. A randomized, double-blind, parallel-group, dose-response study of micafungin compared with fluconazole for the treatment of esophageal candidiasis in HIV-positive patients.
    de Wet N, Llanos-Cuentas A, Suleiman J, Baraldi E, Krantz EF, Della Negra M, Diekmann-Berndt H.
    Clin Infect Dis; 2004 Sep 15; 39(6):842-9. PubMed ID: 15472817
    [Abstract] [Full Text] [Related]

  • 36. Influence of hemodialysis on zidovudine (AZT) and its glucuronide (GAZT) pharmacokinetics: two case reports.
    Garraffo R, Cassuto-Viguier E, Barillon J, Chanalet L, Lapalus P, Duplay H.
    Int J Clin Pharmacol Ther Toxicol; 1989 Nov 15; 27(11):535-9. PubMed ID: 2613387
    [Abstract] [Full Text] [Related]

  • 37. Pharmacokinetics of oral antifungals and their clinical implications.
    Heykants J, Van Peer A, Lavrijsen K, Meuldermans W, Woestenborghs R, Cauwenbergh G.
    Br J Clin Pract Suppl; 1990 Sep 15; 71():50-6. PubMed ID: 1965419
    [Abstract] [Full Text] [Related]

  • 38. Pharmacokinetics of orally administered zidovudine among patients with hemophilia and asymptomatic human immunodeficiency virus (HIV) infection.
    Morse GD, Olson J, Portmore A, Taylor C, Plank C, Reichman RC.
    Antiviral Res; 1989 Mar 15; 11(2):57-65. PubMed ID: 2729955
    [Abstract] [Full Text] [Related]

  • 39. Interactions of antineoplastic chemotherapy with zidovudine pharmacokinetics in patients with HIV-related neoplasms.
    Toffoli G, Errante D, Corona G, Vaccher E, Bertola A, Robieux I, Aita P, Sorio R, Tirelli U, Boiocchi M.
    Chemotherapy; 1999 Mar 15; 45(6):418-28. PubMed ID: 10567772
    [Abstract] [Full Text] [Related]

  • 40. Population pharmacokinetics of nevirapine, zidovudine, and didanosine in human immunodeficiency virus-infected patients. The National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group Protocol 241 Investigators.
    Zhou XJ, Sheiner LB, D'Aquila RT, Hughes MD, Hirsch MS, Fischl MA, Johnson VA, Myers M, Sommadossi JP.
    Antimicrob Agents Chemother; 1999 Jan 15; 43(1):121-8. PubMed ID: 9869576
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.